Intratympanic Botulinum Toxin Injection as a New Therapeutic Modality for Middle Ear Myoclonic Tinnitus
Jung Mee Park(Catholic University of Korea), Jae Sang Han(St. Mary's Hospital), Min Ja Kim(Gachon University), So Y. Park(The Catholic University of Korea Yeouido St. Mary's Hospital), Shi Nae Park(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 8
Related Papers
Tinnitus in patients with profound hearing loss and the effect of cochlear implantation
|European Archives of Oto-Rhino-Laryngology|2012|39
Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy
|Acta Oto-Laryngologica|2013|36
Age-related hearing loss in the Korea National Health and Nutrition Examination Survey
|PLoS ONE|2020|35
Simvastatin provides long‐term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy
|Physiological Reports|2019|30
Sesquiterpenoids from <i>Chrysanthemum indicum</i> with Inhibitory Effects on NO Production
|Journal of Natural Products|2021|29